volgoat, you've been around for at least as long as I have. I skip over most posters these days, but I always read your comments. I address this post to you for 2 reasons: (a)you are excellent at TA and you have a firm grasp of the science behind BAVI and (b)you seem upbeat even after yesterday's kick in the tush (per your post to Dr. Rocker that things are "heating up").
At this point, I really don't know what to think about this company. I've always been convinced about the science, but have had nothing but disdain for management. But it really makes no difference whether this investment fails (after almost 14 years)because of either science or management. The following historical items keep coming back to me and I cannot shake their negative effect:
(1) This company has a history of false starts. We get good news which rallies the stock one day, only to find that there is some informational tidbit which catastrophically collapses the share price shortly after. Look at a weekly chart. Since 2000 the share price has been on a steady decline with periodic spikes (2000, 2001, 2003, 2006, 2009, 2012). Except for 2012, every spike has registered a lower high than the previous spike.
Again, on a weekly chart, since 2003 every major low has been a lower low than the previous one.
(2) It was reported that the breast cancer trial had CRs (and as I recall, these people were suffering from advanced stages of the disease). Yet, next to nothing about it (that I can remember) in health or biotech news. Isn't that odd?
(3) IF our scientific data are so convincing, I cannot believe that one of the major drug companies would not have partnered with us -- on our terms. I know many have speculated here that management simply will not settle for the peanut price being offered by BP. But that's only speculation on our part (like
almost every thing else about this company). BUT if we truly have all the patents to PS immunotherapy locked up, I wouldn't think that any BP would risk letting PPHM go to someone else. It just doesn't make sense.
(4)Someone always seems to know ahead of time when bad news (or even news which could be seen as negative such as yesterday)is about to released and shorts the hell out of the stock. This gives me a very uneasy sense that big $ is consistently being made off the backs of the retail investors from info being provided by company insiders. It does nothing to form a perception of an honest company and its leadership.
(5) Things being done to the retail investors that seem to intentionally harm us: the pre-market release of the dosing disaster last September being the most egregious (and yesterday's pre-market release of a disastrously written communication being another).
When I step back from all of this, it is difficult to avoid the perception that something is seriously wrong.
Would you, in your generosity, explain why you remain optimistic? In fact, anyone who reads this post, I would very much like to read a summary of why you remain optimistic (if you do).
Perhaps this is the time for a sober, calm, objective reflection by the most knowledgeable IHUB Board minds of why investors should remain optimistic.
TIA.
Sean
P.S. Fred, I cannot respond to private emails. Thank you for returning to the Board. If you see this, I'd very much enjoy your reflection as well.
AI
